MedTrace Logo

Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert

NCT00880932 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1865

Last updated 2009-04-14

No results posted yet for this study

Summary

The hypothesis is that a newly formatted electronic alert that requires the prescriber to pause and enter a specific "reason for override" on this alert, will cause prescribers in the intervention group to be significantly less likely to prescribe the combination of warfarin and NSAID than prescribers in the control group.

Conditions

  • Warfarin and NSAID

Interventions

BEHAVIORAL

Electronic Alert

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00880932 on ClinicalTrials.gov